Domenech joined Heartland in 2009 after several years working and writing on national health care policy, beginning with a political appointment as speechwriter to U.S. Health and Human Services Secretary Tommy Thompson, and continuing as chief speechwriter for U.S. Senator John Cornyn during the Medicare Part D debate on Capitol Hill.
In addition to his work with Heartland and The Federalist, Domenech is the publisher of a daily subscription newsletter, The Transom, which is read daily by thousands of political insiders.
Domenech co-founded Redstate andhosts a popular podcast on market issues in the global economy -- and for which he won a "Sammy" award in 2011 — called Coffee & Markets.
In 2009 he was selected as a Journalism Fellow by the Peter Jennings Project for Journalists and the Constitution.
Latest posts by Benjamin Domenech (see all)
- Three Potential Paths Post-Obamacare Ruling - March 14, 2015
- Heartland Daily Podcast – Ben Domenech: The Vaccine Debate - February 6, 2015
- The Insane Vaccine Debate - February 5, 2015
This week I interviewed Avik Roy, a health care analyst on Wall Street and author of The Apothecary blog, about how Obamacare effects pharmaceutical innovation. As we’ve discussed in recent issues of Health Care News, the question of keeping the current U.S. lead in medical innovation isn’t a foregone conclusion — and Roy, who’s written on the clogged pharma pipeline before, gives some excellent perspective on how the industry is responding to a pile of new taxes, some of which make little sense at all.
You can listen to a prior podcast with Roy here, where he makes the Market Case for Health Care in eloquent terms. Listen and learn.